(NYSE: EVH) Evolent Health's forecast annual revenue growth rate of 3.46% is not forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 10.65%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.33%.
Evolent Health's revenue in 2025 is $2,554,741,000.On average, 5 Wall Street analysts forecast EVH's revenue for 2025 to be $241,172,753,737, with the lowest EVH revenue forecast at $240,456,417,724, and the highest EVH revenue forecast at $241,961,609,444. On average, 5 Wall Street analysts forecast EVH's revenue for 2026 to be $283,577,886,994, with the lowest EVH revenue forecast at $274,478,880,622, and the highest EVH revenue forecast at $297,447,336,778.
In 2027, EVH is forecast to generate $331,143,344,461 in revenue, with the lowest revenue forecast at $316,990,345,005 and the highest revenue forecast at $357,561,732,686.